BioSante Pharmaceuticals (BPAX) enters a merger deal with ANI Pharmaceuticals in an all-stock...


BioSante Pharmaceuticals (BPAX) enters a merger deal with ANI Pharmaceuticals in an all-stock deal with BPAX as the surviving company. Former BPAX shareholders will own ~47%. Shares halted.

From other sites
Comments (1)
  • altut
    , contributor
    Comments (7) | Send Message
     
    is it good or bad for bpax shareholders all I see we lost already .30 cents as share holders. It seems to be it may pay off in the near or long term basis.
    5 Oct 2012, 03:08 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs